NeuroSpa Mental Health & Wellness - St. Petersburg
4419 Park Boulevard, Pinellas Park
4.7(82 Google reviews)
United States
7 listed treatment centers serving St. Petersburg and the surrounding area.
4419 Park Boulevard, Pinellas Park
4.7(82 Google reviews)
3957-3959 58th Street North, St. Petersburg
4.8(41 Google reviews)
2191 9th Avenue North, Suite 235, St. Petersburg
5.0(8 Google reviews)
26843 Tanic Drive, Suite 101, Wesley Chapel
5.0(2 Google reviews)
603 7th Street South, Ste 590, St. Petersburg
5.0(2 Google reviews)
Every dose is given in a certified healthcare setting, followed by at least two hours of monitoring. Arrange transportation home after each visit. Distances below are straight-line miles from St. Petersburg.
11.6 miles away · Clearwater
13.6 miles away · Tampa
13.7 miles away · Clearwater
2963 Gulf To Bay Boulevard, Suite 250, Clearwater
5.0(94 Google reviews)
14.2 miles away · Tampa
14.2 miles away · Tampa
1001 South MacDill Avenue, Suite #800, Tampa
4.7(52 Google reviews)
For people in St. Petersburg considering SPRAVATO®, understanding the full visit cost matters as much as checking medication coverage. The medication and the supervised treatment and monitoring visit may be billed separately. Ask for an explanation of all expected charges and your estimated out-of-pocket responsibility before scheduling treatment.
Coverage varies by plan. Prior authorization is common, and your insurer may request records of earlier antidepressant trials. Ask the treatment center which records it needs, who submits the authorization request, and how you will learn whether treatment has been approved. Approval should not be assumed simply because a center offers Spravato.
Medicare coverage may fall under Part B or Part D depending on the plan and treatment setting. Florida Medicaid coverage also depends on the plan and setting. Confirm both your benefits and whether the center accepts your coverage; a directory listing does not establish either.
Manufacturer savings programs exist for eligible commercially insured patients, but they are not for patients using government insurance such as Medicare or Medicaid. Ask about current eligibility rules and which charges a program may help with rather than assuming it covers the entire visit.
Before starting, ask the center and insurer:
Keep the insurer’s response and any written estimate for reference.
SPRAVATO® treatment requires repeated visits to a healthcare setting certified through the Spravato REMS program. You administer the nasal spray yourself under a healthcare provider’s direct observation; it is never supplied for use at home. Confirm the location’s current certification before arranging treatment.
Plan for at least two hours of monitoring after each dose, plus any time needed for check-in, preparation, and discharge assessment. The typical labeled schedule for treatment-resistant depression starts twice weekly during weeks 1–4, then weekly during weeks 5–8. Maintenance may be weekly or every two weeks. Your prescriber determines the schedule appropriate for you; do not assume your appointments will follow a fixed pattern.
You need someone else to drive you home after every treatment. Do not drive or operate machinery until the next day after a restful sleep. Arrange rides before booking, and ask the center about its pickup and discharge requirements. If you plan to use a hired ride, confirm whether an accompanying person is required. Having a backup driver can help prevent transportation problems from disrupting appointments.
For work planning, allow time for the whole visit and transportation, and discuss any driving or machinery-related job duties with your clinician. Consider childcare or other responsibilities that may need coverage that day.
Start with St. Petersburg listings, but verify availability directly. If no suitable local center is listed or accepting patients, review listings in Pinellas Park, Largo, Tierra Verde, Clearwater, or Tampa. These are search options, not confirmation of certification or appointment availability. Compare the practical demands of repeated trips before committing.
Start with the St. Petersburg directory listings, then contact the treatment location directly. Ask whether it is currently certified through the SPRAVATO® REMS program and accepting new patients. The supplied listings do not confirm REMS certification. If local options do not meet your needs, you can also review listings in Pinellas Park, Largo, Tierra Verde, Clearwater, or Tampa and verify each location’s status.
Spravato is approved for adults with treatment-resistant depression, either alone or with an oral antidepressant. It is also approved for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior, together with an oral antidepressant. It is not approved for children. A clinician must review your symptoms, previous treatments, and health history to determine whether it is appropriate for you.
Coverage depends on your plan, the treatment setting, and authorization requirements. Ask your insurer about both the medication and the monitored visit, which may be billed separately. Previous antidepressant treatment records may be needed. Medicare and Florida Medicaid may cover treatment depending on the plan and setting, but you must separately confirm that the center accepts your coverage. A listing is not a coverage guarantee.
You self-administer the nasal spray under a healthcare provider’s direct observation in a REMS-certified setting. Staff monitor you for at least two hours afterward for effects such as sedation, dissociation, breathing problems, and increased blood pressure. Allow extra time beyond monitoring for other visit steps. Someone else must take you home, and you cannot drive or operate machinery until the next day after a restful sleep.
Discuss sedation, dissociation—a sense of disconnection from yourself or your surroundings—breathing problems, and blood pressure increases. Spravato has boxed warnings for sedation, dissociation, respiratory depression, abuse and misuse, and suicidal thoughts and behaviors. It is a Schedule III controlled substance. Tell the clinician about your health history and medicines so they can assess risks and explain what to report during and after treatment.
No. Spravato has not been shown to prevent suicide or reduce suicidal thoughts or behavior, and it does not replace hospitalization when needed. Its approval for depressive symptoms in adults with major depressive disorder with acute suicidal thoughts or behavior requires use with an oral antidepressant. If you are in crisis, call or text 988. If there is immediate danger or a medical emergency, call 911 rather than waiting for an appointment.
Approved uses, nearby treatment centers, and medically sourced patient guides.